Nimbic
Back to search
DXR

DXR

HealthcareMedical Instruments & Supplies

$10.94

Last close

Market Cap

$0.1B

Employees

N/A

Type

Public

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Leads

AI-generated opportunities from financial data

DXR (DXR) — Financial Highlights & AI Enterprise Leads | Nimbic